CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Treatment of Older Adults with Insomnia, Agitation, or Delirium With Benzodiazepines: Clinical Effectiveness and Guidelines

Last updated: April 23, 2015
Project Number: RB0838-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of the treatment of older adults with insomnia, agitation, or delirium with benzodiazepines or other sedative hypnotic agents?
  2. What are the evidence-based guidelines for the treatment of older adults with insomnia, agitation, or delirium with benzodiazepines or other sedative hypnotic agents?

Key Message

Three systematic reviews, three randomized controlled trials, and two evidence based guidelines were identified regarding the treatment of older adults with insomnia, agitation, or delirium with benzodiazepines or other sedative hypnotic agents.